Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome

Endocrine

Volumn 54, Issue 2, 2016, Pages 411-421

  Guillín Amarelle, Cristina ^a,b   Sánchez Iglesias, Sofía ^a   Castro Pais, Ana ^b,c   Rodriguez Cañete, Leticia ^a,b   Ordóñez Mayán, Lucía ^b,c   Pazos, Marcos ^b,c   González Méndez, Blanca ^a   Rodríguez García, Silvia ^a   Casanueva, Felipe F ^b,c   Fernández Marmiesse, Ana ^b   Araújo Vilar, David ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

Body composition; Familial partial lipodystrophy; Visceral adipose tissue

Indexed keywords

HEMOGLOBIN A1C; INSULIN; LEPTIN; LIPID;

ADIPOSE TISSUE; ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BODY COMPOSITION; BODY FAT DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FAMILIAL PARTIAL LIPODYSTROPHY; FAMILY HISTORY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; INSULIN BLOOD LEVEL; INTRAPERITONEAL FAT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC DISORDER; MUTATION; PHENOTYPE; PRIORITY JOURNAL; SKINFOLD; WOMEN'S HEALTH; BLOOD; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; INSULIN RESISTANCE; LIPODYSTROPHY, FAMILIAL PARTIAL; MIDDLE AGED; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; SYMPTOM ASSESSMENT;

ABSORPTIOMETRY, PHOTON; ADULT; BODY COMPOSITION; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; LIPIDS; LIPODYSTROPHY, FAMILIAL PARTIAL; MIDDLE AGED; PHENOTYPE; SYMPTOM ASSESSMENT;

EID: 84979994375     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-016-1002-x     Document Type: Article

References (28)

1. H. Cao, R.A. Hegele, Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 9, 109–112 (2000)
2. I. Barroso, M. Gurnell, V.E. Crowley, M. Agostini, J.W. Schwabe, M.A. Soos et al., Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402, 880–883 (1999)
3. A.K. Agarwal, A. Garg, A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J. Clin. Endocrinol. Metab. 87, 408–411 (2002)
4. K. Tan, W.A. Kimber, J. Luan, M.A. Soos, R.K. Semple, N.J. Wareham, S. O’Rahilly, I. Barroso, Analysis of genetic variation in Akt2/PKB-beta in severe insulin resistance, lipodystrophy, type 2 diabetes, and related metabolic phenotypes. Diabetes 56, 714–719 (2007)
5. O. Rubio-Cabezas, V. Puri, I. Murano, V. Saudek, R.K. Semple, S. Dash et al., Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. Embo. Mol. Med. 1, 280–287 (2009)
6. S. Gandotra, C. Le Dour, W. Bottomley, P. Cervera, P. Giral, Y. Reznik et al., Perilipin deficiency and autosomal dominant partial lipodystrophy. N. Engl. J. Med. 364, 740–748 (2011)
7. S.M. Farhan, J.F. Robinson, A.D. McIntyre, M.G. Marrosu, A.F. Ticca, S. Loddo et al., A novel LIPE nonsense mutation found using exome sequencing in siblings with late-onset familial partial lipodystrophy. Can. J. Cardiol. 30, 1649–1654 (2014)
8. K.L. Herbst, L.R. Tannock, S.S. Deeb, J.Q. Purnell, J.D. Brunzell, A. Chait, Kobberling type of familial partial lipodystrophy: an underrecognized syndrome. Diabetes Care 26, 1819–1824 (2003)
9. A. Garg, R.M. Peshock, J.L. Fleckenstein, Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J. Clin. Endocrinol. Metab. 84, 170–174 (1999)
10. T.P. Nedungadi, D.J. Clegg, Sexual dimorphism in body fat distribution and risk for cardiovascular diseases. J. Cardiovasc. Transl. Res. 2, 321–327 (2009)
11. B. Donadille, O. Lascols, J. Capeau, C. Vigouroux, Etiological investigations in apparent type 2 diabetes: when to search for lamin A/C mutations? Diabetes & Metabolism 31, 527–532 (2005)
12. D. Araujo-Vilar, L. Loidi, F. Dominguez, J. Cabezas-Cerrato, Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation. Horm. Metab. Res. 35, 29–35 (2003)
13. R.A. Hegele, C.M. Anderson, J. Wang, D.C. Jones, H. Cao, Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Res. 10, 652–658 (2000)
14. A. Garg, Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J. Clin. Endocrinol. Metab. 85, 1776–1782 (2000)
15. G. Bidault, M. Garcia, M.C. Vantyghem, P.H. Ducluzeau, R. Morichon, K. Thiyagarajah et al., Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 33, 2162–2171 (2013)
16. M.C. Vantyghem, D. Vincent-Desplanques, F. Defrance-Faivre, J. Capeau, C. Fermon, A.S. Valat et al., Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy. J. Clin. Endocrinol. Metab. 93, 2223–2229 (2008)
17. H.F. Escobar-Morreale, J.L. San Millan, Abdominal adiposity and the polycystic ovary syndrome. Trends. Endocrinol. Metab. 18, 266–272 (2007)
18. M.G. Dunnigan, M.A. Cochrane, A. Kelly, J.W. Scott, Familial lipoatrophic diabetes with dominant transmission. A new syndrome. Q. J. Med. 43, 33–48 (1974)
19. J. Kobberling, B. Willms, R. Kattermann, W. Creutzfeldt, Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipatrophic diabetes. Humangenetik 29, 111–120 (1975)
20. J. Kobberling, M.G. Dunnigan, Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state. J. Med. Genet. 23, 120–127 (1986)
21. S.N. Jackson, T.A. Howlett, P.G. McNally, S. O’Rahilly, R.C. Trembath, Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophy. Q. J. Med. 90, 27–36 (1997)
22. M.S. Treuth, G.R. Hunter, T. Kekes-Szabo, Estimating intraabdominal adipose tissue in women by dual-energy X-ray absorptiometry. Am. J. Clin. Nutr. 62, 527–32 (1995)
23. J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1990)
24. J.C. Levy, D.R. Matthews, M.P. Hermans, Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21, 2191–2192 (1998)
25. D.W. Hosmer, S. Lemeshow, E. Cook, Applied Logistic Regression. 2nd ed. John Wiley & Sons, New York, NY (2000)
26. A.D. Bohr, K. Laurson, M.B. McQueen, A novel cutoff for the waist-to-height ratio predicting metabolic syndrome in young American adults. BMC Public Health 16, 295 (2016)
27. M.B. Snijder, J.M. Dekker, M. Visser, L.M. Bouter, C.D. Stehouwer, P.J. Kostense et al., Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am. J. Clin. Nutr. 77, 1192–1197 (2003)
28. S. Yusuf, S. Hawken, S. Ounpuu, L. Bautista, M.G. Franzosi, P. Commerford et al., Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366, 1640–1649 (2005)